Skip to main content

As cancer drug therapies continue to improve and oncology research gives patients more options, treatments and time, winning the war against cancer is a goal increasingly within reach. However, whether removing a tumor, limb, breast or node, or administering a groundbreaking new chemotherapy or targeted...

FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations     ROCKVILLE, MD – A trio of papers co-authored by four National...

[vc_row][vc_column][vc_single_image image="53531" img_size="full" alignment="center"][vc_column_text]A cancer diagnosis is a devastating blow for anyone to experience, but when you find out your mom has cancer, your whole world turns upside down.  After a lifetime of Mom nursing your wounds and taking care of you when you’re sick, suddenly...

The Play4TheCure team is excited to take our fundraising activities on the road this Spring and Summer as we visit Minor League Baseball teams around Maryland and Virginia! Our partnership with Minor League Baseball (MiLB) was initiated by one of our motivated youth ambassadors, Ally...

[vc_row][vc_column][vc_column_text] Skin cancer is the most common form of cancer in the United States. Approximately 9,500 people are diagnosed with skin cancer every day in the U.S. That’s well over 3 million diagnoses every year. Fortunately, skin cancer is one of the most preventable and treatable...

May is Cancer Research Awareness Month, a time highlighting the vital role of study and experimentation in the quest for cancer cures. As such, it is a particularly special month for the National Foundation for Cancer Research (NFCR). If fact, our Svent-Györgyi Prize for Progress...

[caption id="attachment_25678" align="alignnone" width="1050"] 2017 Szent-Györgyi Prize Winner Michael N. Hall, Ph.D., with Selection Committee Chair Mary-Claire King, Ph.D., and Co-Chair Sujuan Ba, Ph.D.[/caption] The discovery of rapamycin in 1972 did not create major waves in the oncology community. But in 1989, Michael N. Hall, Ph.D.,...